Obesity Clinical Trial
Official title:
Efficacy of a Structured Exercise Prescription Program Over Anthropometric, Metabolic and Fitness Parameters in Obese Children and Adolescents Included in a Multicomponent Lifestyle Intervention Program. Randomized Clinical Trial
This controlled clinical trial aims to compare the effects of a multicomponent program that
includes structured personalized exercise prescription in children with obesity with a
control group that will be enrolled in a multicomponent program without structured
personalized exercise prescription. All children will be followed for a period of 6 months.
The parameters that will be evaluated between groups are physical fitness, anthropometry,
metabolic (glucose oral tolerance curve, lipids, HOMA-IR, ISI-MATSUDA), early cardiovascular
damage, inflammatory biomarkers, anxiety and depression scores, and allelic variants related
to physical fitness.
This controlled clinical trial aims to compare the effects of a multicomponent program that
includes structured personalized exercise prescription in children with obesity (study group)
with a control group that will be enrolled in a multicomponent program without structured
personalized exercise prescription. All children will be followed for a period of 6 months.
The parameters that will be evaluated between groups are physical fitness (measured by
VO2max, ECG at rest, biomechanics and dynamometry), anthropometric measurements (weight
height, BMI, plicometry, bioimpedance, metabolic (glucose oral tolerance curve, lipids,
HOMA-IR, ISI-MATSUDA), early cardiovascular damage (carotid intima-media thickness,
atherogenic dyslipidemia), inflammatory biomarkers (leptin, adiponectin, IL-17, IL-10,
INF-gamma, IL-6, IL-12, y TNF-alpha), anxiety and depression scores evaluated with Child
Depression Inventory (CID) and -Trait Anxiety Inventory for Children (STAI-CH), and allelic
variants related to physical fitness (ACTN, TRH2 y FTO).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |